Tenon Medical Inc (TNON)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $3.79M
Last updated: Nov 17, 2026 at 4:33 PM ET
Tenon Medical Inc (TNON) Statistics
Tenon Medical (TNON) has a market cap of $3.79M. It kept -305.10% of revenue as net income over the last 12 months. It holds $8.27M more cash than debt, 218.17% of its market cap.
Total Valuation
| Market Cap | $3.79M |
|---|---|
| Latest price (Nov 17, 2026) | $1.25 |
Key Dates
The next earnings report is expected on Mar 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 0.3x.
| P/S Ratio | 0.3x |
|---|---|
| Forward P/S | 0.7x |
| P/B Ratio | 0.3x |
| P/TBV Ratio | 0.5x |
Price Statistics
The stock is down 96.97% over 52 weeks and trades 57.04% below its 50-day average.
| Beta (1Y) | 1.31 |
|---|---|
| 52-Week Change | -96.97% |
| 1-Month Change | -48.98% |
| 3-Month Change | -89.04% |
| 6-Month Change | -94.90% |
| Total Return (1Y) | -96.97% |
| Total Return (3Y CAGR) | -86.90% |
| Return vs SPY (1Y) | -108.40% |
| Max Drawdown (1Y) | -96.89% |
| Max Drawdown (3Y) | -99.79% |
| Sharpe Ratio (1Y) | -1.89 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $2.91 |
| 200-Day Average | $15.22 |
| 52-Week Range | $1.30 to $40.95 |
| RSI (14 Days) | 25.7 |
| Average Volume (20 Days) | 122.82K |
Financial Position
Current assets cover 2.93x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 2.93x |
|---|---|
| Quick Ratio | 2.70x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -184.39% and return on assets is -104.93% over the last 12 months.
| Return on Equity (ROE) | -184.39% |
|---|---|
| Return on Assets (ROA) | -104.93% |
| Return on Capital Employed (ROCE) | -124.34% |
| Asset Turnover | 0.42x |
| Inventory Turnover | 2.22x |
| Receivables Turnover | 3.05x |
| Cash Conversion Cycle | 157 days |
Scores
TNON has an Altman Z-Score of -10.36, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -10.36 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $5.57M over the last 12 months is up 72.32% from the 12 months before.
| Revenue | $5.57M |
|---|---|
| Revenue Growth (YoY) | +72.32% |
| Gross Profit | $3.73M |
| Operating Income | -$12.59M |
| Pretax Income | -$17.00M |
| Net Income | -$17.00M |
| EBIT | -$15.38M |
| Reported EPS (TTM) | -$28.81 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 56.91% of the $16.20M in total assets.
| Cash and Equivalents | $8.27M |
|---|---|
| Total Debt | $0 |
| Net Cash | $8.27M |
| Net Cash Per Share | $6.72 |
| Working Capital | $7.39M |
| Shareholder Equity | $9.22M |
| Book Value Per Share | $4.99 |
| Tangible Book Value | $6.37M |
| Tangible Book Per Share | $2.68 |
| Total Assets | $16.20M |
| Total Liabilities | $6.98M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $428.00K of capital spending, operating cash flow left -$10.76M of free cash flow.
| Operating Cash Flow | -$10.33M |
|---|---|
| Capital Expenditures | $428.00K |
| Free Cash Flow | -$10.76M |
| FCF Per Share | -$4.00 |
| Depreciation and Amortization | $2.34M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -225.90%.
| Gross Margin | 66.88% |
|---|---|
| Operating Margin | -225.90% |
| Pretax Margin | -305.10% |
| Net Margin | -305.10% |
| EBIT Margin | -276.00% |
| FCF Margin | -193.11% |
| Gross Margin (5Y Average) | 25.45% |
Growth
Revenue grew 78.71% a year over 3 years.
| Revenue Growth (3Y CAGR) | +78.71% |
|---|---|
| Revenue Growth (5Y CAGR) | +145.95% |
Dividends and Yields
TNON does not pay a dividend. Its free cash flow yield is -699.14%.
| FCF Yield | -699.14% |
|---|---|
| Buyback Yield | -691.73% |
| Shareholder Yield | -691.73% |
Stock Splits
The last split was a 1-for-35 reverse split on Aug 10, 2026.
| Last Split Date | Aug 10, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:35 |
Peer Position
Against 6 similar companies, TNON has the 6th highest P/S.
P/S RatioPeer median 0.6x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +18.57%
| P/S Ratio | 0.3x vs 0.6x median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +72.32% vs +18.57% median |
Analyst Forecast
Consensus estimates put revenue growth at 49.95% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +49.95% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About TNON
What is TNON's market cap?
Tenon Medical has a market cap of $3.79M.
How many shares of TNON are outstanding?
Tenon Medical has 1.23M shares outstanding.
Does TNON pay a dividend?
No. Tenon Medical does not pay a dividend.
How much debt does TNON have?
Tenon Medical has $0 of total debt and $8.27M of cash and equivalents, a net cash position of $8.27M.
TNON pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors